Lactate Transporter SLC16A3 (MCT4) as an Onco-Immunological Biomarker Associating Tumor Microenvironment and Immune Responses in Lung Cancer
Qingsong Tao,1,* Xin Li,2,* Ting Zhu,1 Xiaoqin Ge,1 Shengping Gong,1 Jianxin Guo,1 Ruishuang Ma1,3 1Department of Radiotherapy and Chemotherapy, Ningbo First Hospital, Ningbo, People’s Republic of China; 2Department of Respiratory Medical Oncology, Harbin Medical University Cancer Ho...
Main Authors: | Tao Q, Li X, Zhu T, Ge X, Gong S, Guo J, Ma R |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-04-01
|
Series: | International Journal of General Medicine |
Subjects: | |
Online Access: | https://www.dovepress.com/lactate-transporter-slc16a3-mct4-as-an-onco-immunological-biomarker-as-peer-reviewed-fulltext-article-IJGM |
Similar Items
-
Prognostic value of lactate transporter SLC16A1 and SLC16A3 as oncoimmunological biomarkers associating tumor metabolism and immune evasion in glioma
by: Ting Zhu, et al.
Published: (2022-10-01) -
Generation of iPSC lines with SLC16A2:G401R or SLC16A2 knock out
by: Katarzyna Anna Ludwik, et al.
Published: (2023-12-01) -
A SLC16A1 Mutation in an Infant With Ketoacidosis and Neuroimaging Assessment: Expanding the Clinical Spectrum of MCT1 Deficiency
by: Sara Al-Khawaga, et al.
Published: (2019-07-01) -
Lactate Induces the Expressions of MCT1 and HCAR1 to Promote Tumor Growth and Progression in Glioblastoma
by: Lucia Longhitano, et al.
Published: (2022-04-01) -
Untargeted metabolomics identifies the potential role of monocarboxylate transporter 6 (MCT6/SLC16A5) in lipid and amino acid metabolism pathways
by: Tianjing Ren, et al.
Published: (2022-06-01)